Literature DB >> 34815521

Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes.

Gabriela de Carvalho Nunes1, Punnanee Wutthigate1, Jessica Simoneau1, Marc Beltempo1, Guilherme Mendes Sant'Anna1, Gabriel Altit2.   

Abstract

OBJECTIVE: Evaluate spontaneous closure of the patent ductus arteriosus (PDA) in extremely preterm infants and their respiratory outcomes, especially at <26 weeks gestational age (GA). STUDY
DESIGN: Retrospective study in <29 weeks, admitted within 24 h after birth (Feb 2015 and Dec 2019). Infants without any intervention to promote ductal closure, ≥1 echocardiography, and alive at discharge were included.
RESULTS: Two hundred and fourteen infants (average GA 26.3 ± 1.5 weeks) were included; 84 (39%) <26 weeks. PDA closed spontaneously in 194 (91%); 76/84 (90%) for infants <26 weeks. PDA closure was ascertained on an echocardiography performed at a median age of 36.4 [34.4-40.1] weeks. Rate of moderate-to-severe bronchopulmonary dysplasia decreased throughout the study period (OR for year of birth: 0.70 [95% CI: 0.57-0.87], p = 0.001).
CONCLUSION: Majority of extremely preterm infants, including <26 weeks, had spontaneous closure of the ductus before term corrected age. There was a concomitant improvement of respiratory outcomes.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34815521     DOI: 10.1038/s41372-021-01277-2

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  37 in total

Review 1.  How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate?

Authors:  D S Urquhart; R M Nicholl
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

Review 2.  Learning to live with patency of the ductus arteriosus in preterm infants.

Authors:  W E Benitz
Journal:  J Perinatol       Date:  2011-04       Impact factor: 2.521

Review 3.  Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature.

Authors:  Gabriel Altit; Adrian Dancea; Claudia Renaud; Thérèse Perreault; Larry C Lands; Guilherme Sant'Anna
Journal:  Paediatr Respir Rev       Date:  2016-11-09       Impact factor: 2.726

Review 4.  The use of non-steroidal anti-inflammatory drugs for patent ductus arteriosus closure in preterm infants.

Authors:  William E Benitz; Shazia Bhombal
Journal:  Semin Fetal Neonatal Med       Date:  2017-07-17       Impact factor: 3.926

5.  Counselling and management for anticipated extremely preterm birth.

Authors:  Brigitte Lemyre; Gregory Moore
Journal:  Paediatr Child Health       Date:  2017-08-11       Impact factor: 2.253

6.  Patent ductus arteriosus: to treat or not to treat?

Authors:  William E Benitz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2011-12-15       Impact factor: 5.747

7.  Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.

Authors:  Matthew Laughon; Michael T O'Shea; Elizabeth N Allred; Carl Bose; Karl Kuban; Linda J Van Marter; Richard A Ehrenkranz; Alan Leviton
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

8.  Natural evolution of patent ductus arteriosus in the extremely preterm infant.

Authors:  Audrey Rolland; Shivani Shankar-Aguilera; Douty Diomandé; Véronique Zupan-Simunek; Pascal Boileau
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-08-28       Impact factor: 5.747

Review 9.  Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.

Authors:  Souvik Mitra; Ivan D Florez; Maria E Tamayo; Lawrence Mbuagbaw; Thuva Vanniyasingam; Areti Angeliki Veroniki; Adriana M Zea; Yuan Zhang; Behnam Sadeghirad; Lehana Thabane
Journal:  JAMA       Date:  2018-03-27       Impact factor: 56.272

10.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

View more
  2 in total

Review 1.  The role of furosemide and fluid management for a hemodynamically significant patent ductus arteriosus in premature infants.

Authors:  Sarah Dudley; Shawn Sen; Alison Hanson; Afif El Khuffash; Philip T Levy
Journal:  J Perinatol       Date:  2022-07-15       Impact factor: 3.225

2.  Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.

Authors:  Anna Gudmundsdottir; Marco Bartocci; Oda Picard; Joanna Ekström; Alexander Chakhunashvili; Kajsa Bohlin; Caroline Attner; Gordana Printz; Mathias Karlsson; Lilly-Ann Mohlkert; Jonna Karlén; Cecilia Pegelow Halvorsen; Anna-Karin Edstedt Bonamy
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.